CASI Pharmaceuticals, Inc.
CASI
$1.94
$0.22713.27%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 16.09M | 20.81M | 12.73M | 19.66M | 30.77M |
| Total Receivables | 15.35M | 11.14M | 7.74M | 6.07M | 10.14M |
| Inventory | 5.25M | 12.93M | 14.61M | 15.42M | 15.88M |
| Prepaid Expenses | 2.89M | 2.27M | 2.11M | 2.00M | 2.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 39.58M | 47.15M | 37.20M | 43.15M | 59.34M |
|
|
|||||
| Total Current Assets | 39.58M | 47.15M | 37.20M | 43.15M | 59.34M |
| Net Property, Plant & Equipment | 11.36M | 12.40M | 10.25M | 10.85M | 11.63M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 238.00K | 1.12M | 1.36M | 1.62M | 1.84M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 587.00K | 702.00K | 692.00K | 702.00K | 766.00K |
| Total Assets | 53.67M | 63.62M | 51.27M | 58.01M | 75.27M |
|
|
|||||
| Total Accounts Payable | 2.72M | 1.76M | 792.00K | 583.00K | 4.44M |
| Total Accrued Expenses | 8.47M | 12.98M | 4.11M | 7.96M | 7.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 19.61M | -- | 429.00K | -- | 728.00K |
| Total Finance Division Other Current Liabilities | 5.66M | -- | 4.25M | -- | 4.41M |
| Total Other Current Liabilities | 5.66M | -- | 4.25M | -- | 4.41M |
| Total Current Liabilities | 36.45M | 14.74M | 9.58M | 8.54M | 16.73M |
|
|
|||||
| Total Current Liabilities | 36.45M | 14.74M | 9.58M | 8.54M | 16.73M |
| Long-Term Debt | -- | 19.12M | 18.47M | 18.59M | 18.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.54M | -- | 1.38M | -- | 1.62M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 12.84M | 15.91M | 12.82M | 15.41M | 13.87M |
| Total Liabilities | 51.82M | 49.77M | 42.25M | 42.54M | 51.10M |
|
|
|||||
| Common Stock & APIC | 713.30M | 712.60M | 699.37M | 696.52M | 695.79M |
| Retained Earnings | -700.08M | -685.71M | -677.31M | -670.35M | -660.82M |
| Treasury Stock & Other | -11.38M | -13.05M | -13.04M | -10.71M | -10.80M |
| Total Common Equity | 1.85M | 13.85M | 9.02M | 15.47M | 24.17M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.85M | 13.85M | 9.02M | 15.47M | 24.17M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.85M | 13.85M | 9.02M | 15.47M | 24.17M |
|
|
|||||